Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-01

FDA Approved: CARISOPRODOL — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Carisoprodol submitted by Westminster Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carisoprodol (Carisoprodol)

Snippet

SUPPL AP for CARISOPRODOL (CARISOPRODOL)